NYSE:EQ - Equillium News Headlines

$3.90
-0.15 (-3.70 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$4.05
Now: $3.90
$4.05
50-Day Range
$3.31
MA: $4.63
$5.67
52-Week Range
$3.10
Now: $3.90
$19.69
Volume13,067 shs
Average Volume29,744 shs
Market Capitalization$67.77 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Equillium (NYSE EQ) News Headlines

Source:
DateHeadline
Equillium (NYSE:EQ) Receives Consensus Recommendation of "Buy" from AnalystsEquillium (NYSE:EQ) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - August 21 at 6:49 AM
Equillium (NYSE:EQ) Releases Quarterly  Earnings Results, Beats Estimates By $0.04 EPSEquillium (NYSE:EQ) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - August 13 at 9:32 AM
Equillium (NYSE:EQ) Rating Reiterated by HC WainwrightEquillium (NYSE:EQ) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - August 13 at 8:03 AM
Equillium Reports Second Quarter 2019 Financial Results and Recent HighlightsEquillium Reports Second Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - August 12 at 8:32 PM
-$0.34 EPS Expected for Equillium (NYSE:EQ) This Quarter-$0.34 EPS Expected for Equillium (NYSE:EQ) This Quarter
www.americanbankingnews.com - August 6 at 5:20 PM
Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled AsthmaEquillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
finance.yahoo.com - July 10 at 11:32 AM
Equillium to Present at Jefferies 2019 Healthcare ConferenceEquillium to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 24 at 11:33 AM
Equillium Expands Scientific and Clinical Advisory TeamEquillium Expands Scientific and Clinical Advisory Team
finance.yahoo.com - May 6 at 10:46 AM
Equillium to Present at Solebury Trout Class of 2018 Biotech IPO Investor DayEquillium to Present at Solebury Trout Class of 2018 Biotech IPO Investor Day
finance.yahoo.com - April 17 at 10:53 AM
Equillium to Present at H.C. Wainwright Global Life Sciences ConferenceEquillium to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 29 at 10:28 AM
Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent HighlightsEquillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
finance.yahoo.com - March 28 at 10:31 AM
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus NephritisEquillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
finance.yahoo.com - February 27 at 9:16 AM
Equillium to Present at Leerink Partners Global Healthcare ConferenceEquillium to Present at Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 22 at 8:51 AM
Equillium to Host Business Update Call on February 26Equillium to Host Business Update Call on February 26
finance.yahoo.com - February 20 at 9:15 AM
Equillium up 12% premarket on Orphan Drug tag for itolizumabEquillium up 12% premarket on Orphan Drug tag for itolizumab
seekingalpha.com - February 7 at 3:27 PM
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host DiseaseEquillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
finance.yahoo.com - February 7 at 8:28 AM
FDA grants Fast Track designation to Equilliums EQ001 for the treatment of aGVHDFDA grants Fast Track designation to Equillium's EQ001 for the treatment of aGVHD
seekingalpha.com - December 19 at 3:19 PM
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host DiseaseEquillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
finance.yahoo.com - December 19 at 3:19 PM
Equillium Inc.Equillium Inc.
www.barrons.com - December 14 at 3:19 PM
Equillium Reports Third Quarter 2018 Financial Results and Recent HighlightsEquillium Reports Third Quarter 2018 Financial Results and Recent Highlights
finance.yahoo.com - November 16 at 5:22 AM
Equilliums IPO: What You Need To KnowEquillium's IPO: What You Need To Know
finance.yahoo.com - November 14 at 3:49 PM
Equillium Announces Pricing of Initial Public OfferingEquillium Announces Pricing of Initial Public Offering
finance.yahoo.com - November 14 at 3:49 PM
Equillium to Present at Investor Conferences in November 2018Equillium to Present at Investor Conferences in November 2018
finance.yahoo.com - November 14 at 3:49 PM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Featured Article: Call Option Volume

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel